Paper Details
- Home
- Paper Details
Factors affecting drug concentrations and QT interval during thioridazine therapy.
Author: DalyA K, FerrierI N, ReillyJ G, ThanacoodyR H K, ThomasS H L
Original Abstract of the Article :
The objective of this study was to investigate factors affecting steady-state plasma concentrations of thioridazine. A cross-sectional study of patients receiving chronic thioridazine was employed. Common allelic variants of CYP2D6 and CYP2C19, as well as thioridazine and metabolite concentrations a...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1038/sj.clpt.6100195
データ提供:米国国立医学図書館(NLM)
Thioridazine: A Desert Oasis with Potential Side Effects
Thioridazine, a medication used to treat mental health conditions, can be a valuable tool for managing symptoms. However, like a desert oasis, it can also come with potential side effects. This research delves into the desert of pharmacokinetics, investigating factors that influence the steady-state plasma concentrations of thioridazine and its impact on the QT interval, a measure of heart rhythm. The researchers conducted a cross-sectional study of patients receiving chronic thioridazine, examining the influence of age, sex, CYP2D6 and CYP2C19 genotypes, and thioridazine and metabolite concentrations on plasma levels and QT interval. Their findings revealed that thioridazine concentrations were influenced by age, smoking, and CYP2D6 genotype, but not by CYP2C19 genotype. Interestingly, CYP2D6 genotype did not appear to affect the QT interval.
Thioridazine: A Balancing Act
This research highlights the importance of understanding the factors that influence drug metabolism and potential side effects. The findings suggest that careful consideration of individual patient characteristics, such as age, smoking status, and CYP2D6 genotype, is crucial for optimizing thioridazine therapy and minimizing the risk of adverse effects.
Navigating the Desert of Mental Health Treatment
Mental health conditions are complex, and effective treatment requires a personalized approach. This research provides valuable insights into the pharmacokinetics of thioridazine, emphasizing the need for individualized monitoring and dose adjustments to ensure patient safety and efficacy.
Dr.Camel's Conclusion
This research underscores the importance of understanding the factors that influence thioridazine pharmacokinetics and its potential impact on heart rhythm. It emphasizes the need for careful monitoring and dose adjustments to optimize treatment and minimize the risk of adverse effects. It is a reminder that the desert of mental health treatment is vast and complex, requiring a personalized approach to ensure patient safety and well-being.
Date :
- Date Completed 2007-11-28
- Date Revised 2022-12-07
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.